In addition to ALK fusion, RET proto-oncogene (RET) or v-ros UR2 sarcoma virus oncogene homolog 1 (ROS1) are rearranged in approximately 1% of NSCLC. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.